Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

Recent & Breaking News (TSXV:SBM)

Sirona Biochem Begins Cell Preservation Research Collaboration With Dr. Caigan Du, University of British Columbia

Marketwired April 11, 2016

Sirona Biochem Selected to Present at BIO-Europe Spring

Marketwired March 21, 2016

Promo watch: Sirona Biochem (V.SBM) burning up the charts on the back of German interest

Chris Parry January 27, 2016

Sirona Biochem Invited to Present at Dose of the Valley Conference, San Francisco

Marketwired January 25, 2016

Sirona Biochem Announces Positive Results With New Glycoproteins for Anti-Aging and Regenerative Medicine

Marketwired November 10, 2015

Sirona Biochem Retains Strategic Advisor to Commercialize Glycoproteins

Marketwired November 3, 2015

Sirona Biochem Presents New Results From Glycoprotein Program at BIO-Europe

Marketwired October 26, 2015

Sirona Announces Warrants Exercised

Marketwired September 28, 2015

Sirona to Attend Cosmetic360 Conference in Paris

Marketwired September 24, 2015

Sirona Biochem Reaches Major Milestone by Successful Scale-Up of Skin Lightening Compound SBM-TFC-1067

Marketwired September 15, 2015

Sirona Biochem Appoints German Private Bank Hauck & Aufhauser as Designated Sponsor For Xetra(R)

Marketwired September 11, 2015

Sirona Retains Momentum Public Relations Inc. for Investor Relations

Marketwired September 1, 2015

Sirona Announces Results of Shareholder Meeting

Marketwired August 25, 2015

Sirona Biochem Announces SGLT2 Inhibitor and Skin Lightening Patent Granted

Marketwired June 29, 2015

Sirona Biochem Appoints Casper Bych to Its Board of Directors

Marketwired June 26, 2015

Sirona Biochem CEO Update: Significant Interest From Top Cosmetic and Pharmaceutical Companies for Lead Compounds

Marketwired June 3, 2015

Sirona Biochem Discovers Unexpected Ancillary Effects of Its Anti-Aging Compound

Marketwired May 20, 2015

Sirona Biochem to Present at Industry's Premier Conference -- BIO International Convention 2015

Marketwired May 4, 2015

Sirona Biochem Announces Resignation of Board Director

Marketwired May 1, 2015

Sirona Biochem to Present at BioNetwork East -- May 2015

Marketwired April 13, 2015